Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) Other Non Operating Income (2016 - 2017)

Bone Biologics (BBLG) has disclosed Other Non Operating Income for 2 consecutive years, with -$2.8 million as the latest value for Q3 2017.

  • On a quarterly basis, Other Non Operating Income changed 0.17% to -$2.8 million in Q3 2017 year-over-year; TTM through Sep 2017 was -$8.5 million, a N/A change, with the full-year FY2018 number at -$408294.0, changed N/A from a year prior.
  • Other Non Operating Income was -$2.8 million for Q3 2017 at Bone Biologics, roughly flat from -$2.8 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.8 million in Q2 2016 to a low of -$2.8 million in Q1 2016.